Exagen (XGN) EBT Growth (1y) (2019 - 2026)
Exagen (XGN) EBT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -161.54% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 7.04% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 9.39% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 14.63% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 56.92% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -27.03% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.55% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -13.74% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.82% |
| 10 | Exagen | 102.82 Mn | 81.30 Mn | 10.21 Mn | -4.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.77% |
| Dec 31, 2025 | -24.30% |
| Sep 30, 2025 | -40.93% |
| Jun 30, 2025 | -48.42% |
| Mar 31, 2025 | -11.67% |
| Dec 31, 2024 | 32.33% |
| Sep 30, 2024 | 7.15% |
| Jun 30, 2024 | 40.83% |
| Mar 31, 2024 | 56.30% |
| Dec 31, 2023 | 63.35% |
| Sep 30, 2023 | 35.80% |
| Jun 30, 2023 | 65.83% |
| Mar 31, 2023 | 25.16% |
| Dec 31, 2022 | -119.79% |
| Sep 30, 2022 | -17.50% |
| Jun 30, 2022 | -128.86% |
| Mar 31, 2022 | -65.44% |
| Dec 31, 2021 | -101.46% |
| Sep 30, 2021 | -66.64% |
| Jun 30, 2021 | -90.60% |